Statistics for Inmune Bio (id:5553 INMB)

Valuation metrics

Market cap

101.11M

Enterprise value

73.79M

Trailing P/E (ttm)

-2.92

Forward P/E

-2.24

PEG ratio

-2.24

Price/Sales (ttm)

2.41K

Price/Book (mrq)

2.61

Enterprise Value/Revenue

1.76K

Enterprise Value/EBITDA

-2.48

Overview

Shares outstanding

22.17M

Float

14.31M

Shares short

3.48M

% Held by insiders

0.29%

% Held by institutions

0.24%

Average volume (10 days)

201.65K

Average volume (90 days)

Price summary

52-Week low

4.45

52-Week high

14.74

52-Week change

-91.17%

Beta

1.85

50-Day moving average

5.49

200-Day moving average

8.67

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-98,921.43%

Operational effectiveness

Return on assets

-44.97%

Return on equity

-98.96%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

0.00

Net income to common (ttm)

-41,272,000.00

Diluted EPS (ttm)

-2.18

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

33.55M

Total cash per share (mrq)

1.51

Total debt (mrq)

2.91M

Total Debt/Equity (mrq)

7.53

Current ratio (mrq)

259.40%

Book value per share (mrq)

1.74

Cash flow

Cash flow statement

-25,749,000.00

Levered free cash flow (LFCF)

-10,763,875.00